Plavsic Mark
CIK 0001868719
Chief Technology Officer
Filings
8
Latest Mar 3, 2026
Issuers covered
2
Showing
8 of 8
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 60% | -3.3% | +3.0% | +11.1% | -25.3% |
| 90 days | 5 | 80% | +4.4% | +15.0% | +26.2% | -42.3% |
| 180 days | 4 | 75% | +13.3% | +10.4% | +46.8% | -14.5% |
| 365 days | 3 | 100% | +30.2% | +34.1% | +39.6% | +16.8% |
Issuers
Companies where Plavsic Mark has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AURA | Aura Biosciences, Inc. | 6 | Mar 3, 2026 |
| FATE | Fate Therapeutics Inc | 2 | Jan 11, 2023 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|